New York City’s public hospital system is set to implement an innovative addiction treatment program at Lincoln Hospital, located in the South Bronx. This initiative, named “Hotspotting,” follows the success of a similar program on Staten Island that significantly reduced overdose deaths.
The launch is made possible through a generous grant of $660,000 from the Robin Hood Foundation. The Hotspotting program is designed to provide comprehensive support for patients struggling with opioid addiction. It will focus on those most at risk of relapse, ensuring they receive the necessary help long after they leave the hospital.
At Lincoln Hospital, patients who visit the emergency department for opioid-related issues will be assigned to a dedicated care team. This team will comprise community health workers and peer counselors who have walked similar paths. Over the course of up to one year, they will reach out biweekly to offer ongoing support. This includes connecting patients to addiction services, medical care, social resources, welfare benefits, and even housing assistance when necessary.
In an effort to keep communication open and continuous, patients will receive a cell phone along with a service contact. This tool aims to help them stay engaged with their recovery and access available resources.
Initial expectations for the program are high, with an estimated 150 individuals at the highest risk set to benefit from its services. A study conducted on the Hotspotting initiative by Northwell Health in Staten Island revealed promising results. Out of 612 participants, there were only two fatal overdoses, starkly contrasting with the 14 deaths recorded among 1,089 individuals who were not part of the program. Furthermore, participants in the program experienced a 36% reduction in non-fatal overdoses and a 63% reduction in emergency room visits related to substance use disorders.
Mitchell Katz, the president and CEO of Health + Hospitals, emphasized the urgent need for innovative solutions in response to the growing opioid crisis in New York City. “The increasing potency of opioids in our city requires new and innovative support for our patients with opioid use disorder,” he stated. The Hotspotting program aims to provide crucial follow-up care for patients after their hospital discharge, enhancing their chances of sustained recovery.
Data indicates that New York City has witnessed a troubling rise in fatal overdoses, more than doubling since the onset of the COVID-19 pandemic. Overdose deaths surged from 1,452 in 2018 to a staggering 3,046 in 2023. This crisis is particularly acute in the Bronx, which leads the city in opioid overdose deaths. Health officials caution that individuals who survive nonfatal overdoses face a significantly heightened risk of fatal overdoses in the future.
Joseph Conte, executive director of the Staten Island Performing Provider System (SIPPS), expressed pride in collaborating with NYC Health + Hospitals to bring the Hotspotting program to fruition. He highlighted that the opioid epidemic poses a serious challenge, particularly affecting black and Latino communities like the South Bronx. Conte underscored the urgent need for proactive and innovative strategies to combat this public health crisis, which lies at the heart of the Hotspotting approach.
As Lincoln Hospital prepares to roll out this new treatment program, Dr. Daniel Schatz, the medical director of substance use disorder services at Health + Hospitals, expressed eagerness about its potential. “Our Hotspotting program will provide continuity of care as patients transition from the hospital to community settings, helping them stay connected to healthcare and addiction services,” he said.
In conclusion, the introduction of the Hotspotting program at Lincoln Hospital represents a proactive step towards addressing the opioid crisis, particularly in underserved communities. By focusing on comprehensive support and ongoing engagement, this initiative aims to turn the tide on addiction in New York City and save lives in the process.
